A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc™) in patients with locally advanced or metastatic cancer

Title
A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc™) in patients with locally advanced or metastatic cancer
Authors
Keywords
Curcumin, Lipocurc, Phase I cancer trials, Colon carcinoma, Prostate carcinoma, Hemolysis
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 82, Issue 4, Pages 695-706
Publisher
Springer Nature America, Inc
Online
2018-08-03
DOI
10.1007/s00280-018-3654-0

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started